ETNB
Price
$9.95
Change
+$0.14 (+1.43%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
1.42B
42 days until earnings call
SNDX
Price
$9.29
Change
+$0.39 (+4.38%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
765.82M
46 days until earnings call
Interact to see
Advertisement

ETNB vs SNDX

Header iconETNB vs SNDX Comparison
Open Charts ETNB vs SNDXBanner chart's image
89bio
Price$9.95
Change+$0.14 (+1.43%)
Volume$27.65K
Capitalization1.42B
Syndax Pharmaceuticals
Price$9.29
Change+$0.39 (+4.38%)
Volume$64.71K
Capitalization765.82M
ETNB vs SNDX Comparison Chart in %
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. SNDX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Buy and SNDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ETNB: $9.76 vs. SNDX: $8.90)
Brand notoriety: ETNB and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 50% vs. SNDX: 82%
Market capitalization -- ETNB: $1.42B vs. SNDX: $765.82M
ETNB [@Biotechnology] is valued at $1.42B. SNDX’s [@Biotechnology] market capitalization is $765.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, ETNB is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 3 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • ETNB’s TA Score: 3 bullish, 6 bearish.
  • SNDX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than ETNB.

Price Growth

ETNB (@Biotechnology) experienced а -2.40% price change this week, while SNDX (@Biotechnology) price change was -8.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

ETNB is expected to report earnings on Aug 07, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.43B) has a higher market cap than SNDX($766M). ETNB YTD gains are higher at: 24.808 vs. SNDX (-32.678). SNDX has higher annual earnings (EBITDA): -318.27M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. SNDX (516M). SNDX has less debt than ETNB: SNDX (1.84M) vs ETNB (37.6M). SNDX has higher revenues than ETNB: SNDX (43.7M) vs ETNB (0).
ETNBSNDXETNB / SNDX
Capitalization1.43B766M186%
EBITDA-380.21M-318.27M119%
Gain YTD24.808-32.678-76%
P/E RatioN/AN/A-
Revenue043.7M-
Total Cash639M516M124%
Total Debt37.6M1.84M2,047%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETNBSNDX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUXAX26.45N/A
N/A
Victory S&P 500 Index A
ABSZX19.92N/A
N/A
AB Discovery Value Z
POVEX30.83N/A
N/A
Putnam International Equity R6
ACEAX9.16N/A
N/A
AB All China Equity A
SGOIX29.13-0.06
-0.21%
First Eagle Overseas I

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-0.56%
AKRO - ETNB
60%
Loosely correlated
+2.08%
IDYA - ETNB
54%
Loosely correlated
+1.06%
DNLI - ETNB
51%
Loosely correlated
+0.35%
CRNX - ETNB
50%
Loosely correlated
-1.71%
SNDX - ETNB
50%
Loosely correlated
-3.47%
More